Circadian variation in blood pressure - Implications for the elderly patient

被引:35
作者
Elliott, WJ
机构
[1] Rush Presbyterian St Lukes Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA
[2] Rush Univ, Rush Med Coll, Dept Prevent Med, Chicago, IL 60612 USA
关键词
hypertension; elderly; diurnal variation; nocturnal decline; silent cerebral damage;
D O I
10.1016/S0895-7061(98)00279-9
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
In most people, blood pressure (BP) displays a characteristic diurnal pattern, with a decline during sleep and a sharp increase around the time of awakening. The early morning surge in BP is synchronous with an increase in the risk of catastrophic cardiovascular events, including acute myocardial Infarction, sudden cardiac,death, and stroke.:Although most clinical investigations have centered on modulating or even preventing the morning surge, emerging data suggest that it may be important to avoid nocturnal hypotension, especially in elderly patients and in those with established atherosclerotic disease. Considerable evidence, has been accumulated to suggest that excessive lowering of:BP at night (whether naturally or through the use of antihypertensive medications) can result in untoward ischemic phenomena, including silent cerebral damage (Binswanger's disease) or ophthalmologic symptoms (eg, anterior ischemic optic neuropathy). Controlled-onset extended-release verapamil, through its unique delivery system, tends to diminish the morning BP surge, whereas it preserves a normal nocturnal BP decline; its effect on preventing early morning cardiovascular catastrophes (while preserving relatively normal nocturnal BP) is currently being tested in a large, international clinical trial. Am J Hypertens 1999; 12:43S-49S (C) 1999 American Journal of Hypertension, Ltd.
引用
收藏
页码:43S / 49S
页数:7
相关论文
共 23 条
[1]
Rationale and design for the controlled onset verapamil investigation of cardiovascular endpoints (CONVINCE) trial [J].
Black, HR ;
Elliott, WJ ;
Neaton, JD ;
Grandits, G ;
Grambsch, P ;
Grimm, RH ;
Hansson, L ;
Lacoucière, Y ;
Muller, J ;
Sleight, P ;
Weber, MA ;
White, WB ;
Williams, G ;
Wittes, J ;
Zanchetti, A ;
Fakouhi, TD .
CONTROLLED CLINICAL TRIALS, 1998, 19 (04) :370-390
[2]
Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death [J].
Cohen, MC ;
Rohtla, KM ;
Lavery, CE ;
Muller, JE ;
Mittleman, MA .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (11) :1512-+
[3]
Circadian variation in the timing of stroke onset - A meta-analysis [J].
Elliott, WJ .
STROKE, 1998, 29 (05) :992-996
[4]
CIRCADIAN VARIATION IN THE TIME OF REQUEST FOR HELICOPTER TRANSPORT OF CARDIAC PATIENTS [J].
FROMM, RE ;
LEVINE, RL ;
PEPE, PE .
ANNALS OF EMERGENCY MEDICINE, 1992, 21 (10) :1196-1199
[5]
*GD SEARL CO, 1998, COV HS PACK INS
[6]
THE EFFECT OF FOOD, TIME OF DOSING, AND BODY POSITION ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF VERAPAMIL AND NORVERAPAMIL [J].
GUPTA, SK ;
YIH, BM ;
ATKINSON, L ;
LONGSTRETH, J .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (11) :1083-1093
[7]
Incidence of nonarteritic anterior ischemic optic neuropathy [J].
Hattenhauer, MG ;
Leavitt, JA ;
Hodge, DO ;
Grill, R ;
Gray, DT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (01) :103-107
[8]
Nonarteritic anterior ischemic optic neuropathy: Time of onset of visual loss [J].
Hayreh, SS ;
Podhajsky, PA ;
Zimmerman, B .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 124 (05) :641-647
[9]
NOCTURNAL ARTERIAL-HYPOTENSION AND ITS ROLE IN OPTIC-NERVE HEAD AND OCULAR ISCHEMIC DISORDERS [J].
HAYREH, SS ;
ZIMMERMAN, MB ;
PODHAJSKY, P ;
ALWARD, WLM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 117 (05) :603-624
[10]
Nonarteritic anterior ischemic optic neuropathy: Role of nocturnal arterial hypotension [J].
Hayreh, SS ;
Zimmerman, MB ;
Podhajsky, P ;
Alward, WL .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (07) :942-943